Also trades as: SABSW (NASDAQ) · $vol 0M
SABS NASDAQ
SAB Biotherapeutics, Inc.
1W: -9.4%
1M: -20.5%
3M: -24.0%
YTD: -20.9%
1Y: +50.5%
3Y: -36.3%
5Y: -97.0%
$2.98
-0.08 (-2.61%)
Weekly Expected Move ±4.6%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-13M
Net Income
+65.5% YoY
$-73M
Free Cash Flow
-137.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-11.3%
ROA-9.5%
ROIC-48.4%
Valuation
P/E0.8
P/B1.1
EV/EBITDA-22.6
Leverage
Debt/Equity0.02
Current Ratio9.22
Interest Cov.-54.2x
Quality Scores
Piotroski F3/9
Altman Z7.38
Beneish M0.00